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Abstract: The publication presents a comparative study of two fibre-optic sensors in the application
of heart rate (HR) and respiratory rate (RR) monitoring of the human body. After consultation
with clinical practitioners, two types of non-invasive measuring and analysis systems based on
fibre Bragg grating (FBG) and fibre-optic interferometer (FOI) have been designed and assembled.
These systems use probes (both patent pending) that have been encapsulated in the bio-compatible
polydimethylsiloxane (PMDS). The main advantage of PDMS is that it is electrically non-conductive
and, as well as optical fibres, has low permeability. The initial verification measurement of the system
designed was performed on four subjects in a harsh magnetic resonance (MR) environment under
the supervision of a senior radiology assistant. A follow-up comparative study was conducted,
upon a consent of twenty volunteers, in a laboratory environment with a minimum motion load and
discussed with a head doctor of the Radiodiagnostic Institute. The goal of the laboratory study was
to perform measurements that would simulate as closely as possible the environment of harsh MR or
the environment of long-term health care facilities, hospitals and clinics. Conventional HR and RR
measurement systems based on ECG measurements and changes in the thoracic circumference were
used as references. The data acquired was compared by the objective Bland–Altman (B–A) method
and discussed with practitioners. The results obtained confirmed the functionality of the designed
probes, both in the case of RR and HR measurements (for both types of B–A, more than 95% of the
values lie within the ±1.96 SD range), while demonstrating higher accuracy of the interferometric
probe (in case of the RR determination, 95.66% for the FOI probe and 95.53% for the FBG probe,
in case of the HR determination, 96.22% for the FOI probe and 95.23% for the FBG probe).
Keywords: interferometer; Bragg grating; heart rate (HR); respiratory rate (RR); phonocardiography
(PCG); ballistocardiography (BCG); electrocardiography (ECG); polydimethylsiloxane (PDMS);
vital signs; non-invasive measurements; patient monitoring; biomedical engineering; magnetic
resonance imaging (MRI)
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1. Introduction
This publication builds on current trends in non-invasive monitoring of vital functions [1].
The original benefit of this work is the comparison of two types of fibre-optic systems, namely
the fibre-optic interferometric (FOI) system and the fibre Bragg grating (FBG) system, and their
verification against conventional clinical systems in use. The electrocardiograph (ECG) and the
contact elastic band with the built-in Piezo-Electric Respiration Transducer (PERT) were used as
a reference. The comparative study is focused on human body pulse rate (HR) and respiratory rate
(RR) monitoring for the harsh magnetic resonance (MR) environment (e.g., Magnetic Resonance,
X-ray, UV absorption and radiation, etc.). Advantageous characteristic features of fibre-optic sensors
include their independence from an active power supply and a high immunity to electromagnetic
interference. Thanks to these attributes, these sensors can be used with other electronic equipment
without generating electrical noise that may compromise the quality of vital sign monitoring and
potentially lead to patient safety concerns. Fibre-optic sensors are gaining more popularity due to their
flexibility, very small dimensions, and reliability. Please see the articles below.
In the research part of this study, two non-invasive probes based on FBG (hereinafter the FBG
probe) and interferometer (hereinafter the FOI probe) were designed and assembled. These probes
are encapsulated in the polydimethylsiloxane (PMDS) polymer, which offers a unique combination
of suitable properties for biomedical applications. The main advantage of PDMS is that it is inert to
human skin, it is electrically non-conductive, it is a diamagnetic substance and it is resistant to UV
radiation [2]. Other benefits include its mechanical and heat resistance, washability and repeatability.
The results presented in [3–7] indicate that these types of encapsulation do not affect the structure and
function of the FBG and FOI probes.
FBG and FOI probes have been designed in consultation with clinical practitioners and devised in
such a way that they were as small as possible and most suitable for application in the field of biosignal
measurement. While the FBG probe can be constructed as extremely compact, the FOI sensor contains
short sections of optical fibre, where the limiting factor is the critical bend radius of the fibre, which is
set to 3 cm for the most common G.652.D single-mode fibres [8]. The FOI sensor uses connection of the
Mach–Zehnder interferometer by means of a coupler with three output ports. The measuring FOI and
FBG probes are part of a contact elastic band located on the patient’s chest (in this study, this elastic
band is replaced with an elastic band with a built-in PERT). Measurement with the FBG probe is
based on sensing the movement of the patient’s thoracic cavity; in the case of the FOI probe, which is
more sensitive, it is also possible to record the murmurs and sounds emitted during the cardiac cycle.
Along with this, expansion of the fibre-optic sensors due to the respiratory activity is also measured.
Table 1 shows a comparison of both systems and takes into account their advantages/
disadvantages/applications possibilities and price of systems/probes.
The main assumed and current area from the point of view of clinical practice is the possibility to
apply such sensors for patients’ HR and RR monitoring in the harsh MR environment, or for the
prediction of the so-called hyperventilation states that occur during these examinations due to
e.g., a closed tunnel environment [9,10]. These are cases when the person begins to breathe
faster and their heart rate increases (tachycardia). Spontaneous breathing is constantly at risk
due to anaesthetics, upper airway obstruction, or panic and claustrophobic conditions during MR
examinations. Another advantage of the fibre-optic probes is the potential to simplify vital sign
monitoring and consequently improve the comfort level of patients in long-term health care facilities,
hospitals and clinics, as one sensor can be used to monitor RR and HR simultaneously.
In the first phase of the comparative study, the fibre Bragg gratings and FOI systems and
probes were tested in a harsh MR environment under the supervision of a senior radiology assistant,
their properties were then verified by long-term testing in a laboratory environment and discussed with
the head radiologist doctor (Petr Krupa). The real issue is to obtain consent from the ethics committee
to carry out a larger study on a larger number of test subjects within the MR environment or in the
environment of the long-term health care facilities, hospitals and clinics. For this reason, the article is
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drawn up in such a way that, after testing the basic functionality of the measuring systems and probes
in the MR environment during standard examinations on four test subjects and within a limited time
interval of tens of minutes, see Section 4.1, the study was moved to a laboratory environment, where it
could be performed on a larger sample of test subjects (different age, weights, heights, and sexes) at
long time intervals (tens of hours) against the HR and RR reference commonly used in clinical practice
(see Section 4.2).
Table 1. A comparison of both fibre-optic systems.
Advantages Disadvantages ApplicationPossibilities
Cost
(Approximately)
Probe/Evaluation
Unit
FBG
system
the feed fibre is not sensitive to
vibrations and other undesirable
effects; one lead-in fibre for
sensor; design of the sensor
(probe) is extremely
compact = small size;
the possibility of
quasi-distributed
measurement-sensors can be
multiplexed on a single optical
fibre with single evaluation unit;
the possibility of remote
evaluation (hundreds meters);
MRI-compatible
costly spectral
evaluation
(higher cost);
low signal-to-noise
ratio (in the case of
multiple probes)
RR and
HR of the
human body
100 $/18,000 $
FOI
system
higher sensitivity; measuring
system can thus be constructed
from commonly available
components (low-cost);
the potential for detecting
acoustic signals (monitoring
respiratory and arousal events);
MRI-compatible
sensor’s
dimensions
(potentially
discomfort);
storing of the
reference arm;
a higher number of
lead-in fibres for
each sensor
RR and HR of
the human
body;
monitoring
respiratory
and arousal
events
200 $/4000 $
On the basis of the literary research below, it can be concluded that a similar comparative study
of such an extent has not been carried out and that further use of the proposed measurement systems
and probes in clinical practice was necessary. The article documents the accuracy of the probes tested
compared to the HR and RR references. The results of this study now serve as a stimulus to get
approval from the Ethics Committee for Clinical Trials; a major clinical study in MR environment and
in long-term health care facilities, hospitals and clinics is being planned.
2. State of the Art
HR measurement is an important factor that can provide information about changes in the blood
circulation and heart activity; therefore, it is often a measured quantity in the medical environment.
Today, various quantities, such as the ECG electrical signal, the acoustic signal, blood pressure changes
in the circulatory system, changes in tissue volume as a result of volume changes in the circulatory
system, changes in tissue impedance associated with changes in the blood volume in a specific
tissue section or changes in blood flow velocity—due to changes in blood pressure in the circulatory
system—are used for its determination [11].
Measurement by means of an electric ECG signal is nowadays a generally recognized
standard [12–15] although this method of determining HR has existed for decades. To measure
the twelve lead ECGs, a connection of three limb electrodes (both upper limbs and left lower limb),
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one ground electrode (right lower limb) and six chest electrodes are used. A one-lead ECG using
three electrodes can also be used to determine the HR, which has been dealt within the study by
the authors [12].
Determining HR by means of an acoustic signal (phonocardiography) usually uses sensitive
microphones that are located in the chest area and its surroundings. The algorithms are then applied
to the resulting signal as we see in the article [16].
The blood pressure varies during the heart activity and fluctuates between two values (HR).
It is the upper limit, systolic pressure—the maximum arterial pressure during the systole, and lower
limit, diastolic pressure—the lowest arterial pressure during the diastole. During life, the systolic
pressure increases, while the diastolic pressure is a measure of peripheral resistance. Depending on the
position of the pressure sensor, we divide pressure measurement methods into direct and indirect [17].
Plethysmography, where body part volume depends on the immediate blood pressure value,
is used to evaluate the HR from tissue volume change. This is enabled by the elasticity of the
bloodstream as well as the tissues. To do this, a photoelectric plethysmograph, which works either
with a translucent sensor or a reflective sensor, is used. Changes in blood pressure alter the volume of
the capillaries, which causes a change in absorption, reflection and scattering of light. This method
is used to measure volume changes and the heart rate. This can be measured in a wearable device,
as shown in the article [18].
The time dependence of tissue impedance changes is an HR function. Its shape is similar to
the shape of the time dependence of pressure changes in the bloodstream. In the cardiotachometer,
the input part is formed by a reograph, whose output signal is shaped in a suitable shaping circuit.
At the output of the shaping circuit, there are pulses, whose frequency corresponds to the heart rate.
In this mode of detection, the effect of the stimulator, if the stimulation was not effective, and the
extrasystoles, which did not expel the blood from the ventricles into the bloodstream, are automatically
excluded from the evaluation. There are a large number of publications dealing with these devices and
their modifications [19,20].
The PERTs are commonly used to determine the respiratory rate. They are applied, for example,
in sleeping laboratories [21]. These are passive devices not requiring electrical power that generate
an electrical signal corresponding to the breathing period. These sensors are fixed to an elastic band that
is fastened around the chest. It generates a high-level, linear signal in response to changes in thoracic
circumference associated with respiration. These belts, however, cannot be used for quantitative
respirative volume measurements. The advantage, however, is that RR belt detection can be very
reliable, even with a range of motion artifacts [22], providing a solid reference signal.
One of the most sensitive methods of monitoring vital functions is the use of fibre-optic
interferometers. The principle of the function is to measure changes in the electromagnetic wave
path due to the action of the forces from the external environment. In the case of interferometers,
these changes can be measured with high accuracy at a value level smaller than the wavelength of
the light. The sensitivity is so high that a range of measurements can also be performed in indirect
contact with the human body. The publication [23] describes a principle of creating a resonator
between the body and the radio frequency (RF) aerial to measure the heart and respiratory rates;
the resulting signal is very similar to the signal from the photoplethysmogram. The article thus proves
that these small changes can also be recorded, even by electromagnetic waves with a much longer
wavelength, e.g., 24 GHz [24]. Due to this fact, smart fabrics containing sensors and monitors of
wearable electronics [25] are created. It is, therefore, obvious that the principle is functional, even with
optical radiation. The basic types of interferometers are multimode ones [26]; they are formed as
follows: a part of the measuring optical fibre with other core properties (hollow or no core, a multi-point
fibre with a larger core, etc.) is placed between or behind the single-point fibre. The advantage is very
cheap production of the sensor, for example based on plastic fibres, described in [27,28].
A sensor assembled on the basis of a speckle interferometer is incorporated in the mattress,
thus making the transmission of the mechanical movements between the body and the sensor indirect;
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linear photodetectors need to be used for scanning. Even so, the results achieved in [27] shown
sensitivity and accuracy of heart rate measurement around 98%. Articles [29–32] were focused on
measuring the respiratory rate. Here, a hollow-core fibre sensor was used (photonic crystal fibre).
The resulting interference between the core and the cladding mode corresponded to the respiratory rate
when the sensor was placed in the respirator mask. The principle is then similar to today’s thermistor
respiration sensors that are used in hospital environments. Michelson interferometers have proved
more practical; even in this case, the sensor may be in direct or indirect contact with the body, but the
respiration and the pulse can be monitored at the same time, as simpler methods and conventional
photodetectors can be used for detection [33]. The resulting measurement accuracy of is more than
95%, according to the authors [34–36]. Mach–Zehnder interferometers [37], which are characterized by
simpler and cheaper production, were also demonstrated. In addition, they can be made using tapers,
as shown in [38], dealing with pulse detection.
The second option, described in the article, regarding the method of monitoring vital functions by
means of a fibre-optic sensor, is to use an FBG sensor. This type of sensor can be used for monitoring
the so-called ballistocardiography (BCG) signals, as the authors of the publications [39–61] have shown.
This is a relatively new non-invasive technique that is primarily used to monitor respiratory activity,
changes and rhythm of cardiac activity. For example, in the article [39], the authors carried out
experimental measurements using an FBG sensor prototype, quantitative and qualitative studies have
been performed and the results are found to be reliable and accurate, validating its potential as a
standalone medical diagnostic device. An electrical stethoscope was used as the reference signal.
The article [43] describes experimental measurements with FBG sensors that can be used to measure
the heart rate and the respiratory rate in the sitting position. The analyzed HR and RR results
corresponded to the results achieved by commercial devices. Very small relative measurement errors
were achieved by the authors of study [56], which focused on the use of the FBG sensor prototype
for measuring BCG signals not only in the sitting but also in the standing position of the body.
Conventional ECG was used as the reference signal; the FBG sensor prototype was characterized by
a relative error of 1.8%. The article [59] describes the use of two FBG sensors encapsulated in the
PDMS polymer. The Bland–Altman (B–A) statistical analysis (the study was performed on 1 min
recordings) demonstrates the HR detection with a satisfactory accuracy in multiple subjects. For the
entire data set, 96.54% of the values lie within the ±1.96 SD (standard deviation) range for the HR
determination. Experimental use of FBG sensors directly in the MR environment is described by the
studies [41,45] and, for example, by thepublication [46], which provides a solution whereby the FBG
sensor is attached to a plexiglas pad on which the patient’s back rests during the examination.
Not many scientific studies or publications dealing with comparison of different signals from
different types of sensors have been published. However, no study is based on extensive evaluation of
phonocardiographic or ballistocardiographic signals sensed by fibre-optic sensors against conventional
ECG devices or respiration sensors. The article [62] describes the initial research focused on comparing
synchronous recordings of BCG, ECG, Carotid Pulse Wave, and phonocardiography (PCG) in acute
pharmacological trials. The article [63] describes the comparison of the Heart Rate Variability (HRV)
indices of the ECG and BCG signals acquired. The results confirmed the feasibility of extracting HR
information from all of the BCG experimental series. A partially relevant study to our research is
described in the publication [64]. This study includes comparison of three signals, phonocardiography
(PCG), electrocardiography (ECG) and photoplethysmography (PPG). However, this article is primarily
focused on describing a new approach used to detect the specific parameters and relations between
the three biomedical signals used in clinical diagnosis.
Table 2 lists the comparison properties of the most interesting fibre-optic sensors (based on both
interferometric and Bragg grating designs) designed for monitoring respiration and heart functions,
which were studied and discussed in prior works. The first column provides a reference to the article/s
(see the reference sheet). The second column presents the type of interferometer and the physiological
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parameter(s) that can be monitored. The third column summarizes the most recent experimental
studies and their results (if it was published).
Table 2. A comparison of the most interesting fibre-optic sensors (based on the both interferometric
and Bragg gratings designs) designed for monitoring respiratory rate and heart rate.
Interferometric Sensors
Reference Type of Interferometer,Measured Parameter Quantitative Data on Sensor Efficiency
[65,66]
(Patents)
Mach–Zehnder, Michelson, Sagnac,
Fabry–Perot (RR and HR) No efficiency data presented by authors
[37,67,68] Mach–Zehnder, Michelson, Sagnac,Fabry–Perot (RR and HR)
Insufficient data, our previously research: No
efficiency data presented by authors
[33–36,69] Michelson (RR and HR)
Most recent, experimental study: recording
time: 60 s; sensitivity: 97.64 ± 7.28%, precision:
99.38 ± 2.80%, maximum relative error:
7.35 ± 7.20% for RR detection, sensitivity:
99.46 ± 1.11%, precision: 99.60 ± 1.05%,
maximum relative error: 3.16 ± 2.32% for HR
detection
[27] Speckle interferometer (RR) Sensitivity: 98.4 ± 1.1%, precision: 98.2 ± 2%
[38] Micro tapered Mach–Zehnder (RR) Insufficient data
[70–72] Fabry–Perot interferometer (RR) No efficiency data presented by authors
Fibre Bragg Grating Sensors
Reference Measured Parameter Quantitative Data on Sensor Efficiency
[39–61] RR and/or HR
Most recent experimental study: An RMS (root
mean square) value of the relative error is
below 1.8%, our previously research (2 FBGs):
maximum relative error 5.41% for RR detection,
sensitivity 96.54% for HR detection
3. Methods
3.1. Interferometric Phonocardiography
The principle of heart rate measurement using the FOI probe is based on the so-called
phonocardiography. Mechanical and acoustic activity of the heart and the mechanical functioning
of the lungs cause changes in the core refractive index and changes in the length of the measuring
optical fibre placed on the body and these microscopic changes in the optical path are appear in the
phase delay of φ in Equation (1) and its difference ∆φ in Equation (2), where λ is the wavelength of the
radiation source, n the refractive index of the optical fibre core, L is the physical length of the fibre.
These changes are then evaluated by the interferometric measuring system:
φ =
2pi
λ
nL, (1)
∆φ =
2pin
λ
∆L+
2pi
λ
L∆n− 2piL n
λ2
∆λ. (2)
The activity of the heart is connected with the creation of a large number of characteristic sounds.
These sounds occur due to changes in the velocity (or the character) of the blood flow and closing
or opening of the respective valves. Hence, this is a diagnostic method that is based on sensing
the acoustic signals (heart sounds) described above, which accompany the mechanical vibrations
originating in the heart and the blood vessels. The conventional electrocardiogram describes the
electrical activity of the heart, while the phonocardiogram describes its mechanical (acoustic) activity.
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The phonocardiographic signal consists of two major sound phenomena: the first one, the so-called
systolic sounds (S1), and, the second one, the so-called diastolic sounds (S2) (please see Figure 1).
The first sound (S1) is associated with the closure of the bicuspid and tricuspid valves at the beginning
of the systole, and its commencement corresponds to the ECG R-wave peak. The second sound (S2) is
induced by the closure of the semilunar valves. The formation and duration of the diastolic sound (S2)
is associated with the ECG T-wave.
Other two sounds, specifically prodiastolic (S3) and presystolic (S4), can be detected using the
phonocardiogram. The prodiastolic sound is caused by the ventricular muscle vibration in the fast
filling phase of the ventricles. The presystolic sound is a manifestation of the ventricular muscle
vibration during the chamber systole. These two sounds, however, are not physiological in adults,
and their presence is a manifestation of heart insufficiency (the so-called protodiastolic and presystolic
gallop) [73–76]. From the point of view of phonocardiography, frequency, intensity, possible changes
or duration of the individual components of the signal are evaluated with the signal being sensed.
Figure 1. Sample recording of electrocardiogram (ECG) and phonocardiography (PCG) signals.
3.2. Grating Ballistocardiography
The second method of measuring respiratory and heart rates is to use the Bragg grating
probe, which consists of a periodic structure of refractive index changes in the optical fibre core.
The principle of measuring respiratory and heart rates using the FBG probe is based on the so-called
ballistocardiography. The respiratory activity is physiologically manifested by the expansion of the
thoracic basket of the human body. This phenomenon exerts pressure on the FBG probe located
in the chest area. Due to this pressure effect, the geometrical and optical properties of the FBG
probe change, which is reflected by a shift in the spectral domain of reflected light, referred to as the
Bragg wavelength:
λB = 2ne f fΛ, (3)
where λB is the Bragg wavelength, ne f f is the effective refractive index of the grating structure in the
fibre and Λ is the spatial period of grating structure refractive index variation. The quantity of the FBG
probe spectral response ∆λB is given by the following relation:
∆λB
λB
= kε+ (αΛ + αn)∆T, (4)
where k is the deformation coefficient, ε is the acting deformation associated with the pressure exerted
by the thoracic basket, αΛ is the coefficient of thermal expansion, αn is the thermo-optic coefficient and
∆T is the change in temperature [77].
The resulting pressure modulation corresponds to the respiration pattern. The pressure
action of the heart activity also occurs in the thoracic area. This response is one to two orders
smaller and is modulated to a more intense signal of the respiratory activity. The measuring
probe achieves high sensitivity to the pressure action, and these very weak heart signals are also
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recorded [59]. The FBG probe (described in more detail in Section 3.4) scans the mechanical action of
the heart. Ballistocardiography falls into the category of non-invasive scanning of body movements.
The movements of the body that are sensed by the sensor cause acceleration of blood that is spread
inside the large vessels. From the medical point of view, the flow of blood hits the so-called aortic
arch that is causing the movement of the body upwards and the subsequent movement of the body
downwards when the blood descends [78]. From the historical point of view, this method has been
known since 1877 (see [79]), but the first documented BCG signal measurement device was constructed
by Isaac Starr in 1936. The current trend in the use of BCG signals for biomedical applications is
rising again, thanks to new technologies, for example fibre-optic sensors (please see articles mentioned
above). Figure 2 shows the waveform and comparison of ECG and BCG signals. H wave is a concave
wave beginning near the origin of R wave, I wave is a small wave following H wave, J wave is the
largest wave of the concave shape following immediately after I wave and K wave is a convex wave
following J wave.
Figure 2. Sample recordings of electrocardiogram (ECG) and ballistocardiography (BCG) signals.
3.3. Non-Invasive Interferometric Measuring System
The interferometric measurement system uses the Mach–Zehnder layout, representing the basic
two-wave interferometer. Optical radiation from a coherent 1550 nm source is fed into a 1 × 2 fibre
splitter that divides it into measuring and reference optical paths. These parts are represented by two
single-mode fibres having an equal length (3 m), wherein the reference part is located in a mechanically
stable loop on the device, while the measuring loop is encapsulated in the PDMS coupling means
to form a vibro-acoustically sensitive probe that can be placed on the human body (see Figure 3).
The PDMS material was chosen after a series of experiments. The idea was to adopt the Young modulus
to the body. The stiff materials such as plastics cannot be easily bent, thereby the human body must
adapt shape to the sensor. On the contrary, too soft materials does not transfer vibrations very well.
Good choices are rubber or silicone type materials, which can be easily bent and the contact with the
skin is always good. The position was chosen to be in the middle of the chest even because the heart is
usually located more on the left-hand side. Thus, we did not have to check where the person’s hearts
are. The sensitivity of the designed sensors also allows sensors to be positioned i.e., on the abdomen
(laboratory tested).
Bending does not affect sensing. In the case of the interferometer, the demodulation process
(discussed below) contains parameters, which compensate the fibre attenuation. Variations in fibre
attenuation can be suppressed using the bending insensitive fibres or by usage of lower wavelengths.
In addition, the demodulation parameters can be recalculated over time and flexibly react to any
unwanted attenuation.
The probe used is made using a 3 m optical fibre loop in a 900 µm tube having a radius of 5–8 cm
and the total weight of the probe is 53 g. The first prototype probes were tested in a number of previous
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experiments [68], and, moreover, the sensitivity was so high that a similar system could be used for
monitoring the foetus, as shown by the authors in [80].
Figure 3. Fibre-optic interferometer measuring probe.
The outputs from both optical paths merge into the second 3 × 3 coupling element forming
the Mach–Zehnder interferometer, which translates the differences in phase delay into intensity
changes, measurable by conventional power photodetectors. This coupling element has, in addition,
three phase-shifted outputs whose output optical intensity can be described by Equation (5), where C
is the mean value of the optical intensity, A is the amplitude of the intensity variation, and m is the
index of the output port of the 3 × 3 fibre coupler assuming values of 1, 2 and 3. This allows easy
passive demodulation of the phase difference between the interferometer arms. The passive homodyne
demodulation method described e.g., in [81,82] can be used for demodulation:
Im (t) = Cm + Am cos
[
∆φ (t) +
2pi
3
(m− 1)
]
. (5)
The signal from the photodetectors is sampled by the National Instruments 9220 measuring
module (Austin, TX, USA) in the cDAQ-9171 chassis, which is supported in the LabVIEW development
environment, which was used to create a custom application that performed data recording,
demodulation according to the above-stated technique, filtration, and RR and HR extraction functions.
Additional signals were also connected to the same measurement module to enable synchronous data
acquisition. The signal processing from the FOI probe to determine the respiratory rate (RR) and the
heart rate (HR) is shown in Figure 4.
Figure 4. The signal processing from the FOI probe to determine the respiratory rate (RR) and the heart
rate (HR).
To determine the RR, a band pass filter of 0 to 0.5 Hz was used, wherein the upper cut-off frequency
can be increased up to 5 Hz. To remove the long-term trend (especially the effect of temperature),
a lower cut-off frequency, e.g., 0.1 Hz, can be introduced to remove this trend. A bandpass filter of 20 to
80 Hz was designed for HR determination, wherein the filter frequencies are based on the knowledge
of the FOI sensors found in [83]. The upper cut-off frequency was further reduced to 50 Hz based on
the findings from the initial MR measurements (see Section 4.1). The filter type used was the third
order Butterworth. Peaks are detected above this signal. Based on their time marks, the respiratory
rate (RR) is calculated according to the following formula: RR = 60/(tn − tn−1), where tn is the time
mark of the n-th peak and tn − 1 is the time mark of the preceding peak. The next step is to smooth
the respiratory rate curve. A median filter with window size 3, which is statistically more resistant
Sensors 2018, 18, 3713 10 of 30
to remote observations than the moving average, is used for smoothing. The heart rate is calculated
using the following relation HR = 60/(tn − tn−1). A median filter with window size 7 is used for
smoothing the heart rate over time.
3.4. Non-Invasive FBG Measuring System
The probe is encapsulated in the PMDS polymer. The results presented in [3] indicate that these
type of encapsulation does not affect the structure and function of the FBG. In the case of the FBG probe
being ideal to place a sensor close to the heart, because FBG in principle records body movements
(chest/heart), please see Section 3.2. Bending of the feed fibre does not affect sensing because FBGs
are spectral sensors where the absolute wavelength changes are evaluated. A photograph of the FBG
probe prototype is shown in Figure 5. The size of the probe is 60× 30× 3 mm, the weight is 5 g,
the shape is also adjusted with respect to the location in the rectangular clamping contact strip.
Figure 5. Fiber Bragg grating measuring probe.
To determine the respiratory and heart rate, the signal from the FBG probe is processed according
to Figure 6. Unwanted signal noise (motion artifacts, muscular activity) is produced by higher
frequencies that are filtered out. To determine RR, a third order bandpass filter with cut-off frequencies
from 0 to 0.5 Hz was used. As in the case of FOI, the trend may be eliminated by changing the lower
cut-off frequency, e.g., the hyperventilation states can be recorded due to the temperature change of
the probe and the change of the upper cut-off frequency. Furthermore, normalization and centring of
the signal to the zero mean value are performed. Peaks are further detected above this signal, followed
by the same signal processing to obtain the RR, which is described in detail in Section 3.3.
A bandpass filter with a cut-off frequency from 5 to 20 Hz was used to acquire the heart rate.
It is selected for more efficient processing so that the output signal was made up of higher harmonics
[59]. The signal filtered in such a way then provides a more reliable representation of the cardiac activity.
Furthermore, the signal is centred and normalized. Peaks are detected above this signal, followed by
the same signal processing to obtain the heart rate, which is described in detail in Section 3.3.
Figure 6. The signal processing from the FBG probe to determine the RR and the heart rate HR.
3.5. Reference Signals
The reference RR signal was obtained using PERT. The advantage of using this method is the
same method of respiration monitoring as with optic fibre probes based on changes in the thoracic
circumference associated with respiration. The Pneumotrace II belt made by UFI (Champaign, IL, USA)
was used [84]. This belt was also used to fasten the FBG and FOI probes. Since typical output signals
reach only 20–50 mV, an electrical amplifier was also inserted between the belt and the analog digital
converter, which amplified the signal to the level of several Volts for better utilization of the ADC
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resolution. This was the above-mentioned module with converters made by National Instruments,
specifically the NI-9220 module in the cDAQ-9171 chassis forming the measuring card.
The reference HR signal was obtained similarly. The reference ECG signal was acquired with
the use of standard gel electrodes fixed to the tested person’s chest using a real-time monitoring
system for an ECG signal with LIFEPAK 15 (Redmond, WA, USA) [85]. The ECG can be directly
sampled using the analogue ECG output cable connected to the measuring module. This allowed
simultaneous and synchronous sampling of data from all sensors at the same time for the purpose of
the comparative study.
3.6. Schematic Diagram of the Measurement
The basic schematic diagram of the measurement with non-invasive FOI and FBG probes,
including the location of the reference ECG and PERT and processing of the signal, is shown in
Figure 7. Electrodes were placed on the volunteers’ bodies and were connected to the LIFEPAK device.
Figure 7. Basic schematic diagram of the measurement.
The ECG output signal, referred to as SECG, is brought to the analog-to-digital converter (ADC).
Furthermore, a fibre probe (FOI probe), which was part of the inteferometer whose outputs SINT were
also connected to the ADC, was placed on the chest area. The second optic fibre probe (FBG probe) was
placed next to this probe and connected to the FBG spectral interrogator unit with superluminescent
diode (SLED) at center wavelength 1549.2 nm and an output power of 1 mW; the output from the SFBG
interrogator was connected to the measuring module as well. Both probes were fastened to the body
using an elastic band, which included PERT. The electrical output from the S′PERT band was amplified
into a SPERT form and was sampled by the same measuring card. The sampling frequency used was
100 kS/s/ch due to the requirement for minimal distortion of the amplitude modulation produced
by the FOI system. A custom application programmed in LabVIEW 2017 (National Instruments,
Austin, TX, USA) and selected scripts programmed in MATLAB (version 2017a) (MathWorks, Natick,
MA, USA) were used for data recording and processing.
4. Results
The initial measurement with the goal to verify the basic functional assumptions of the measuring
systems and probes in the MR environment was performed on four subjects (two males and two
females) during regular examinations, upon their written contest. The subjects tested were between
24 and 47 years of age, their weight was between 45 and 92 kg and their height was between 157
and 186 cm. This measurement is described in more detail in Section 4.1 and was necessary because,
although there are studies that describe practical measurements with fibre-optic sensors in MR scanner,
these studies involve sensors of different constructions with a different implementation method on the
human body, or by the method the information is evaluated and processed [41,45,46,86–94].
The follow-up long-term comparative laboratory measurement was conducted on a group of ten
healthy male adults (hereinafter referred to as M1-M10) and ten female adults (hereinafter referred
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to as F1-F10), upon their written contest. The subjects tested were between 21 and 53 years of age,
their weight was between 47 and 117 kg and their height was between 148 and 197 cm. No significant
differences were found in the quality of the signal received depending on the age, weight, and height.
The aim of the measurements performed was to obtain continuous records from the FOI probe, the FBG
probe and the reference PERT and ECG devices. Long time series were evaluated, a total of 1194 min
of experimental measurement records for respiratory rate measurements and 1197 min of experimental
measurement records for heart rate measurements were analyzed.
The subjects were tested from the point of view of the laboratory experimental measurements
performed in the supine and sitting positions. The experiments were discussed with a senior doctor
and with a radiology assistant. Based on this consultation, all twenty test subjects were asked,
during the experiments, to simulate their natural behaviour in the most accurate way (for instance,
the focus was on the use of fine motor skills—minor movements of hands and arms, feet, legs,
coughing, shallow and deep breathing, etc.). All of these aspects are taken into account in the results
described above regarding the efficiency of both probes. The goal was to record measurements that
would simulate, as closely as possible, the magnetic resonance environment and the environment
for long-term recumbent patients. Based on the results, no significant differences were found in the
quality of the signal received depending on the body position or minor artifacts such as a coughing,
shaking hands, head movement, etc. A graphical illustration of the effect of the above-described body
movements (minor effects), as well as the effect of body movement in full extent or walking (major
effect) on the signal measured obtained by fibre-optic sensors, is shown in Section 4.1.
Both FOI and FBG probes were placed around the pulmonic area on the test subject’s chest and
fixed into the position by a contact elastic band which was part of the PERT (please see Figure 8a,b,
which shows a photograph of the comparative laboratory measurements performed, when subject M1
was in the supine position). During the implementation, the persons being measured did not declare
any restriction of their comfort due to the elastic band used.
(a) (b)
Figure 8. (a) a schematic location of the fibre-optic probes on the human body; (b) a photo of the
location of the fibre-optic probes on subject M1 in the supine body position.
The B–A method [95], based on assessment of the differences between the utilized methods,
was used for objective processing of the results. The differences between the methods, depending on the
averages of these methods, are plotted in the graph. This differential chart allows assessment of whether
the differences are of a systematic nature (whether the difference is systematically different from zero)
and how much the differences vary (their dispersion or standard deviation). The reproducibility is
considered to be good if 95% of the results lie within a ±1.96 SD (Standard Deviation) range.
4.1. The First Phase of the Comparative Study
In the first phase of the comparative study, a pilot measurement was carried out in the MR
environment to verify the functionality of the measuring systems and the probes designed. The aim
was to gain knowledge on the appropriate placement of sensors on the test subjects, installation of
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fibre-optic lead-in cables, and information on whether the probes designed can be used to measure the
vital functions of the human body during an MR examination. During the examination, there are strong
acoustic shocks and subtle mechanical movements of the device and it is necessary to verify whether the
signal obtained from the fibre-optic probes will not be degraded by these artifacts. The measurements
were performed at a private clinic in Prosteˇjov, under the supervision of a senior radiology assistant.
The type of the MR scanner used in the experiment was Signa HDxt 1.5T (GE Healthcare, Chicago,
IL, USA) [96]. The MR scanner is equipped by the manufacturer with the ability to monitor the heart
rate using a PPG sensor and a RR measuring device in the form of a pneumatic sensor. Unfortunately,
the values obtained by these sensors cannot be used in our case as a suitable reference since they
are only informative values, in the form of visual waveforms on the radiology assistant’s monitor,
that cannot be extracted from the device and synchronized with the outputs of the fibre-optic system
being developed.
The waveforms obtained from the fibre-optic sensors were subjectively compared to the
above-stated values from the MR scanner and consulted with a radiology assistant, who confirmed our
initial assumptions about the functionality of the measuring systems and probes designed. No negative
effects on the MR scanner operation were observed during the examinations performed (both types of
probes are not visible in the pictures, i.e., the record is not compromised (see Figure 9)—the location of
the fibre-optic probes is marked in red colour). Continuous recordings of the vital functions from both
types of probes during all procedures performed were made during the examination.
(a) (b)
Figure 9. (a) Photography from the MRI examination; (b) MRI image acquired from the sensor location:
sagittal view—test subject M2 (512 × 512 resolution).
The experimental measurement performed also confirmed that acoustic signals that distorted the
HR measurement in the FOI system proved to be the dominant phenomenon. No artifacts were seen
during the measurements on the FBG system using the FBG probe or for determination of the RR on
both types of the sensory systems (the FBG probe and the FOI probe). Figure 10a shows a signal from
the FOI filtered only by the upper pass filter with a cut-off frequency of 20 Hz corresponding to the
interferometric PCG from which the HR can be determined.
Measurements of typical MR acoustic frequencies can be found in the literature, wherein,
for example, the authors of the study of comparisons of individual types of resonances [97]
report dominant acoustic peaks in the signal around the frequencies of 70, 300, 550 and 1100 Hz
for GE Signa 1.5T magnetic resonance (GE Healthcare, Chicago, IL, USA), which, due to its magnetic
performance, corresponds to the newer HDxt model used during our measurements. The other types
of magnetic resonances mentioned in the publication showed interference in a similar frequency range,
typically 50 to 1000 Hz. These findings were confirmed as artefacts caused by the MR operation
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(Figure 10a) completely disappeared from the signal by limiting the frequency filter for interferometric
PCG from 20–80 Hz to 20–50 Hz and only minor motion artifacts remained (see Figure 10b).
(a)
(b)
Figure 10. (a) Example of a FOI signal from the MRI during the examination; (b) suppression of
undesirable effects by filtration.
In future, another possible way could comprise implementation of probes into the MR system,
where a second FOI probe that would provide a reference differential signal for compensation
of the acoustic noise generated during device operation could be placed inside the MR scanner.
The measurement findings also demonstrate the ability of the FOI probe to read acoustic signals,
so they could also be used as a microphone.
The follow-up measurements were moved to the laboratory environment due to the large number
of test subjects and the inability to use the reference signals directly from the sensors in the MR scanner.
The goal of the laboratory study was to perform measurements that would simulate as closely as
possible the harsh MR environment and the environment of long-term health care facilities, hospitals
and clinics.
4.2. Comparative Measurement of Vital Functions in Laboratory Conditions
4.2.1. Respiratory Rate Measurement
This section provides a study focused on respiratory rate monitoring of the above-stated 20 test
subjects. Figure 11a shows a short example (20 s) of filtered signals, representing the respiratory activity
from both of the fibre-optic sensors and the reference signal, measured on subject M1. Figure 11b
illustrates a similar example of respiratory activity signals of subject F1.
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(a)
FOI probe
(b)
Figure 11. (a) an example of filtered signals representing the respiratory activity of subject M1;
(b) an example of filtered signals representing the respiratory activity of subject F1.
The signals were normalized due to different units on the vertical axis. The congruence of the
period of both of the signals from the fibre-optic sensors with the reference signal is clearly visible.
The reference signal is principally inappropriate for determining the lung volume and the same applies
to the signals from the fibre-optic probes being compared which cannot be compared in terms of the
absolute amplitude. Despite this, there is good congruence of all three signals, especially those from
the probes that we devised. If lung volume measurements are needed, it would be necessary to use
a different reference method as well as fibre-optic sensors of a different construction.
The RR can be subsequently calculated from the filtered respiratory activity signals Figure 12a
shows an example of the RR waveform for subject M1, and Figure 12b is a similar example of RR
waveform for subject F1. RR waveforms are expressed in rpm (respirations per minute). The waveforms
represent 1000 s of the signal recorded. It can be seen from the graphs that the signals from the
probes designed by us correlate with the signal from PERT, wherein, in the case of the M group
subjects, the signals from the probes generally correspond more than in the case of the F group
subjects. This difference is probably caused by the different physiological constitution of the subjects
of the groups.
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(a)
(b)
Figure 12. (a) an example of the RR waveform for subject M1; (b) an example of the RR waveform for
subject F1.
Figure 13 illustrates examples of B–A graphs for the above-stated 1000 s recordings representing
the respiratory activity of subjects M1 and F1. Figure 13a represents the B–A plot for the FBG probe
and the reference PERT for subject M1, Figure 13b represents the B–A plot for the FOI probe and
the reference PERT for subject M1, Figure 13c represents the B–A plot for the FBG probe and the
reference PERT for subject F1 and Figure 13d represents the B–A plot for the FOI probe and the
reference PERT for subject F1. The differences between the probe and the reference traces (x1 − x2) are
plotted against the average (x1 + x2)/2. A number of characteristic features can be derived from the
B–A graphs at first glance. From the differences shown, it is obvious that the they are approximately
symmetrically divided and there are no statistically significant differences between the data analyzed
from the fibre-optic probes and the PERT reference (see Table 3).
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(a) (b)
(c) (d)
Figure 13. (a) B–A plot of M1 subject—FBG probe vs. PERT; (b) B–A plot of M1 subject—FOI probe vs.
PERT; (c) B–A plot of F1 subject—FBG probe vs. PERT; (d) B–A plot of F1 subject—FOI probe vs. PERT.
Table 3. Summary of respiratory measurements.
FBG Probe Interferometric Probe
Sub. Time(s)
ARR
(rpm)
NoS
(-)
Error
(-)
Rel.
Error
(%)
Samples in
±1.96 SD (%)
NoS
(-)
Error
(-)
Rel.
Error
(%)
Samples in
±1.96 SD (%)
M1 3594 17 1025 45 4.39 95.61 1026 45 4.39 95.61
M2 3557 16 957 41 4.28 95.72 957 40 4.18 95.82
M3 3567 18 1057 39 3.69 96.31 1057 38 3.60 96.40
M4 3612 17 1031 38 3.69 96.31 1031 37 3.59 96.41
M5 3512 15 869 41 4.72 95.28 870 40 4.60 95.40
M6 3517 16 939 37 3.94 96.06 939 37 3.94 96.06
M7 3587 15 898 35 3.90 96.10 899 35 3.89 96.11
M8 3574 17 1014 41 4.04 95.96 1015 40 3.94 96.06
M9 3547 15 889 36 4.05 95.95 889 36 4.05 95.95
M10 3568 18 1069 42 3.93 96.07 1071 42 3.92 96.0
F1 3727 15 922 59 6.40 93.60 923 51 5.53 94.47
F2 3624 11 667 37 5.55 94.45 667 35 5.25 94.75
F3 3498 13 761 38 4.99 95.01 762 36 4.72 95.28
F4 3614 12 719 34 4.73 95.27 719 34 4.73 95.27
F5 3608 15 904 39 4.31 95.69 904 39 4.31 95.69
F6 3578 14 835 33 3.95 96.05 836 31 3.71 96.29
F7 3595 14 841 37 4.40 95.60 842 37 4.39 95.61
F8 3587 15 898 42 4.68 95.32 898 41 4.57 95.43
F9 3574 16 954 45 4.72 95.28 955 43 4.50 95.50
F10 3604 14 842 43 5.11 94.89 842 42 4.99 95.01
Sum 71,644 18,091 802 4.47 95.53 18102 779 4.34 95.66
Table 3 describes the overall evaluation of the experimental RR measurements for all 20 test
subjects, including the statistical evaluation within the B–A analysis. Time(s) represents the total
measurement time for the subject, the ARR is expressed in respirations per minute (rpm) and represents
the average respiratory rate of the subject throughout the measurement. NoS represents the number
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of samples measured by FBG and FOI probes, Error means the absolute number of samples that are
outside the ±1.96 Standard deviation (SD) range and Rel. Error indicates the number of defective
samples relative to the total number of samples expressed in percent. For the entire data set (all 20 test
subjects), 95.53% of the values lie within the ±1.96 SD range in RR determination for the FBG probe.
In the case of FOI probe, for the entire data set (all 20 test subjects), 95.66% of the values lie within the
±1.96 SD range in RR determination. It is obvious that the FOI probe offers slightly higher accuracy
(0.13%) in terms of respiratory rate measurement (based on the B–A analysis). The relative error reaches
4.47% in the case of the FBG probe and 4.34% in the case of the FOI probe. Based on the results, it can
be stated that no significant differences between individuals were observed. The represented results
show no systematic errors, and the error has no proportional character and it does not depend on the
RR value. The B–A statistical analysis demonstrates the RR detection with a satisfactory accuracy for
multiple subjects for both the FBG and the FOI probe.
4.2.2. Heart Rate Measurement
This section provides a study focused on heart rate monitoring of the above-stated 20 test subjects.
Figure 14a shows an example of a one-hour correlated HR recording of subject M1 representing the
time waveform of cardiac activity obtained by measurement performed using a prototype of the FOI
probe (labelled PCG) and the FBG probe (labelled BCG) together with an ECG reference (labelled
ECG). Figure 14b shows a similar one-hour HR recording of subject F1. The heart rate waveforms are
expressed in bpm (beats per minute).
(a)
(b)
Figure 14. (a) The HR waveform for subject M1; (b) the HR waveform for subject F1.
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Figure 15a,b with a 10-s recording are provided for a more detailed view of the signals representing
the cardiac activity from both the fibre-optic sensors and the reference signal. The individual maxima
detected in the ECG signal are characteristic of R wave, in the case of the BCG signal from the FBG
probe, the individual maxima characterizing H wave and J wave are marked, and for the FOI producing
the PCG signal, the main sounds S1 and the auxiliary sounds caused by the closing of the semilunar
valves S2 are indicated, which is in line with the theory described in Section 3.
(a)
(b)
Figure 15. (a) An example of 10-s signals representing the cardiac activity of subject M1; (b) an example
of 10-s signals representing the cardiac activity of subject F1.
Figure 16 shows B–A graphs for the above-stated one-hour recordings representing the cardiac
activity of subjects M1 and F1. Figure 16a represents the B–A plot for the FBG probe and the reference
ECG for subject M1, Figure 16b represents the B–A plot for the FOI probe and the reference ECG for
subject M1, Figure 16c represents the B–A plot for the FBG probe and the reference ECG for subject
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F1 and Figure 16d represents the B–A plot for the PCG probe and the reference ECG for subject F1.
The differences between the probe and the reference traces (x1 − x2) are plotted against the average,
(x1 + x2)/2. From the B–A graphs shown, it can be interpreted that there are no statistically significant
differences between the data analyzed from the fibre-optic probes and the references (see Table 4).
(a) (b)
(c) (d)
Figure 16. (a) B–A plot of M1 subject—FBG probe vs. ECG; (b) B–A plot of M1 subject—FOI probe vs.
ECG; (c) B–A plot of F1 subject—FBG probe vs. ECG; (d) B–A plot of F1 subject—FOI probe vs. ECG.
Table 4 describes the overall evaluation of the experimental heart rate measurements for all
20 test subjects, including the statistical evaluation within the B–A analysis. Time(s) represents the
total measurement time for the subject, the AHR represents the average heart rate of the subjects,
NoS represents the number of samples obtained by FBG and FOI sensors, Error means the absolute
number of samples that are outside the ±1.96 Standard deviation (SD) range and Rel. Error indicates
the number of faulty samples relative to the total number of samples expressed in percent. For the entire
data set (all 20 test subjects), 95.23% of the values lie within the ±1.96 SD range in HR determination
for the FBG probe. In the case of FOI probe, for the entire data set (all 20 test subjects), 96.22% of the
values lie within the±1.96 SD range in HR determination. It is obvious that the FOI probe offers higher
accuracy (0.99%) in terms of heart rate measurement (based on the B–A). Based on the results, it can be
stated that no significant differences between individuals were observed. The relative error is 4.77% in
the case of the FBG probe and 3.78% in the case of the FOI probe. The represented results show no
systematic errors, and the error has no proportional character and it also does not it depend on the
HR value. The B–A statistical analysis demonstrates the HR detection with a satisfactory accuracy for
multiple subjects for both the FBG and the FOI probe.
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Table 4. Summary of heart rate measurements.
FBG Probe FOI Probe
Subject Time (s) AHR(bpm)
NoS
(-)
Error
(-)
Rel.
Error
(%)
Samples in
±1.96 SD (%)
NoS
(-)
Error
(-)
Rel.
Error
(%)
Samples in
±1.96 SD (%)
M1 3602 63 3781 171 4.52 95.48 3781 121 3.20 96.80
M2 3547 76 4487 197 4.39 95.61 4489 165 3.68 96.32
M3 3628 77 4664 208 4.46 95.54 4665 158 3.39 96.61
M4 3571 62 3691 185 5.01 94.99 3692 133 3.60 96.40
M5 3498 76 4422 188 4.25 95.75 4422 159 3.60 96.40
M6 3521 75 4398 185 4.21 95.79 4399 157 3.57 96.43
M7 3617 71 4286 169 3.94 96.06 4288 149 3.47 96.53
M8 3647 68 4128 168 4.07 95.93 4131 152 3.68 96.32
M9 3645 66 4028 171 4.25 95.75 4029 147 3.65 96.35
M10 3589 73 4382 185 4.22 95.78 4384 158 3.60 96.40
F1 3507 82 4789 281 5.87 94.13 4781 187 3.91 96.09
F2 3661 81 4941 266 5.38 94.62 4943 189 3.82 96.18
F3 3586 87 5190 275 5.30 94.70 5192 204 3.93 96.07
F4 3608 85 5118 249 4.87 95.13 5128 189 3.69 96.31
F5 3591 82 4905 258 5.26 94.74 4905 197 4.02 95.98
F6 3578 84 5012 247 4.93 95.07 5013 221 4.41 95.59
F7 3617 81 4891 257 5.25 94.75 4893 198 4.05 95.95
F8 3574 78 4653 255 5.48 94.52 4654 207 4.45 95.55
F9 3652 85 5186 243 4.69 95.31 5187 198 3.82 96.18
F10 3589 82 4912 251 5.11 94.89 4913 203 4.13 95.87
Sum 71,828 91,864 4409 4.77 95.23 91,889 3492 3.78 96.22
4.2.3. The Influence of Motion and Acoustic Artifacts on the HR and RR Signals Measured
Before performing the above-stated comparative measurements, the first volunteers were asked
to simulate motion or acoustic artifacts during the laboratory measurements performed. The goal
was to verify their impact on measurements and to allow the test subjects to avoid unwanted motion
artifacts. The motion artifacts analyzed included, for example, slight movement or trembling of the
legs, slight hand movement, torso rotation, head movement, rapid breathing or coughing or snoring.
Many of them, such as shallow breathing, hand movement, and head movement, did not distort the
HR measurements to degrade the signal (see Figure 17a where a hand movement was selected to show
a minor artifact), wherein, for this image, the person was asked to perform these random movements
for 60 s and, then, to stay still. It is fairly obvious that these artifacts also caused slight distortion of the
ECG signal because one of the ECG electrodes was placed on the hand.
Figure 17b shows the effect of major artifacts such as a continuous body movements to the fullest
extent or walking. These movements seriously distorted the resulting BCG and PCG recordings
and prevented correct HR determination. The advantage, however, is that these motion artifacts
are detectable, which can be used, for example, for detecting sudden attacks occurring during the
measurement or long-term monitoring of sleep quality. During the measurements, the test subjects
were asked to remain in a rest position and to avoid major motion artifacts.
On the contrary, no motion artifact had an effect on the RR measurements, but, to determine the
correct rate, it was necessary to shift the upper cut-off frequency of the band pass filter (up to 5 Hz)
when processing the RR signal during rapid breathing. All of these minor movements and sound
aspects are taken into account in the results described above regarding the efficiency of both probes.
In the follow-up research, the authors are ready to carry out a detailed analysis of the influence of
the major artifacts.
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(a)
(b)
Figure 17. (a) an example of the impact of minor effects on the signal measured; (b) an example of the
impact of major effects on the signal measured.
5. Discussion
The results have shown that both types of sensors can reliably monitor both the heart rate and the
respiratory rate simultaneously using a single probe. Because the interferometric principle, which uses
phase difference measurement between two waves, in contrast to measuring the wavelength of the
reflected optical radiation, is generally a more sensitive principle, and this corresponds to the results
achieved, where the interferometric probe (FOI) was able to provide higher accuracy (by 0.99% in the
case of heart rate measurements, by 0.13% in the case of respiratory measurements, according to the
B–A analysis).
The advantage of grating (FBG) sensors is the sensitivity of the probe only at the point of the optical
grating, wherein the lead fibre is not sensitive to vibrations and other undesirable effects. The design
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of the sensor (probe) is extremely compact because the grating itself is inscribed in an optical fibre
having a length <1 cm. Only one fibre can lead to the probe and it can contain a whole range of
FBG sensors that can be used for monitoring at other sites or also other physiological quantities.
Such a quasi-distributed system can measure a number of signals without interacting with each other
through their shift in the spectral region.
The disadvantage is difficult evaluation of the output signal that has to be conducted spectrally,
which, in principle, leads to a higher price for the resulting measuring system. Such a system uses
expensive wide-spectrum sources, the power of which is spread over the entire spectrum, resulting in
individual spectral components reflected by FBG sensors achieving low power and low signal-to-noise
ratios (SNRs). This leads to higher demands on the detection capabilities of the evaluation unit.
Interferometric systems provide higher sensitivity, but this is not so necessary in this particular
application, but the higher achievable accuracy of measurement is the advantage, as the results show.
Another advantage is that, at the output, the interferometer produces amplitude modulation that can be
detected by conventional photodetectors, a radiation source is a coherent laser diode, mass-produced
and used in telecommunications, and the entire measuring system can thus be constructed from
commonly available components, which are thus more affordable. Interferometric systems also have
the potential for detecting acoustic signals (sounds) of frequencies higher than 80 Hz and they could
be used, for example, for monitoring respiratory and arousal events.
In certain cases, the fact that the FOI probe requires a much longer section of the optical fibre
(meters) and is not so compact can be considered to be disadvantageous. In addition, a reference loop of
the same length must be placed in the device and, moreover, it must be isolated from ambient influences
as both loops are sensitive to vibrations and other influencing phenomena. If there is a requirement
for multi-point measurement conducted by interferometers, a problem with multiplexing the sensors
arises. The first problem is the need for a higher number of lead-in fibres for each sensor, wherein this
number increases linearly with the number of sensors when no wavelength division multiplex is used,
which results in a more expensive and more complicated sensory system topology. This is related to
another complication, since each sensor requires its own detection components.
The benefits of both types of the sensory systems include the possibility of remote evaluation of
the quantities measured. The distance is limited by the type of the interconnecting optical fibre used
located between the probes and the evaluation units, which is given by the fibre attenuation coefficient
and, further, by the power and wavelength of the radiation source used. In addition, both types
of systems provide a reduced patient load in the form of a smaller number of sensors placed, since
multiple quantities can be monitored at the same time.
Sweat and temperature present no challenges to interferometric sensor operation. Sensors can
be operated even with indirect contact with skin (i.e., over a T-shirt). Sweat as an extra layer does
not introduce any issues. During the measurements, subjects were occasionally sweating so these
phenomena are already included in the presented results. Temperature changes are apparent in the
measured results with both sensors, nevertheless, the phenomena are effectively filtered out (please
see Section 3.3 and not affecting presented results. In case of grating sensors, of course, these are
dependent on ambient temperature and temperature of patient. However, signals of HR and RR have
fast dynamic character; therefore, slow changes of temperature or sweating have no influence on
evaluation accuracy of HR and RR of human body.
Basically, any fibre interferometric systems can be used. Out of the four most known arrangements
(Mach–Zehnder (MZI), Michelson, Sagnac, Fabry–Perot (FPI)), the MZI was chosen as the sensor can be
cheapest. A slight improvement can bring the Michelson interferometer since it will require single lead
fibre to the sensor. FPI can bring the desired sensor compactness; however, the sensitivity would be
very different from the two before mentioned interferometer configurations. FPI is also very sensitive
to the source wavelength changes; therefore, precise temperature and current controller must be
used in combination with thermoelectric cooler (TEC) compatible laser packaging. Authors [70–72]
presented a Fabry–Perot (FP) interferometer inside the plastic tube; Respiratory Rate tests were carried
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out using a simulated breathing flow system, with relation to thin-film refractive indices and thickness;
but no data on sensor efficiency were presented.
Measurement of HR and RR performed by FBG probe can be theoretically influenced by the
light source due to imperfect thermal stabilization of broadband optical light sources causing changes
of optical output power and shape of the spectral distribution of light, which can influence the
shape of reflected spectra from FBG and therefore influence evaluation of Bragg wavelength shift.
These mentioned changes, fortunately, have slow behaviour in comparison to HR and RR and therefore
can be neglected.
Used optical sources (for FBG as well as for FOI system) were chosen at 1550 nm because the
used silica optical fibres (in case of both probe types) have lowest attenuation and photodetectors’
highest sensitivity at this wavelength. A wavelength of 1550 nm was also chosen with respect to
lower construction costs as telecommunication optical fibres offer low-cost waveguides in comparison
with fibres for different wavelengths. In addition, in the case of the FBG system, this wavelength
allows direct connection into the hospital optical network infrastructure and therefore the possibility
of remote processing and evaluation of data measured by probes.
Compared to the results achieved by other studies, the sensory system devised by us obtains
similar results. The study in the article [46] that uses the FBG sensor achieves slightly higher accuracy
when determining the HR (95.89%) and the RR (96.10%) relative to the reference signal. This may be
due to both the different design of the sensor and the fact that the evaluation was performed on only
12 subjects with a recording length of only 5 min per person. Motion artifacts may not have manifested
themselves sufficiently in such a short time. A similar study on 10 subjects was also provided by the
authors of the article [28] who devised an interferometric sensor that was incorporated into a mattress
but was not designed for the MR environment. Nevertheless, thanks to the nature of the fibre-optic
sensors, it is possible to assume the possibility of its use even in the MR environment. The results
obtained showed a slightly lower sensitivity in determining the RR (95.3%), while, when determining
the HR, the situation was the opposite (99.4%). The study was performed on 2 min recordings.
Dziuda et al. [41] presented an overview article that aims to systematize the knowledge of fibre-optic
techniques for recording life functions and to indicate the current directions of development in this
area. A total of 47 MR-tested or potentially MR-compatible sensors have been described, but no
sensor has been encapsulated in the PDMS polymer. A similar overview article was presented by
Quandt et al. [98] focusing on body monitoring and health supervision by means of optical fibre-based
sensing systems in medical textiles.
The measuring probes presented in this article are relevant or partly relevant to the following
patent documents: a fibre-optic measuring system for monitoring the vital functions of the human
body (document number: 306857) and a device for monitoring vital functions of a pregnant woman’s
foetus (document number: 307183).
6. Conclusions
Fibre-optic sensory systems are increasingly applied in the biomedical industry and are a suitable
and affordable alternative to commonly used devices in terms of HR and RR determination.
The authors of the publication perceive the applicability of the systems and probes designed referred to
in the article as provisional, primarily in the MR environment or for patients with a minimum motion
load (long-term ill patients). This was the reason why this publication, which provides a comparative
study of two fibre-optic non-invasive sensory systems relative to a conventional ECG or a Piezo-Electric
Respiration Transducer in the application of human body HR or RR monitoring, has been compiled.
An extensive study, based on 20 test subjects with a total recording length of 1194 min for the RR
measurement and 1197 min for the HR measurement, was conducted. None of the test subjects who
participated in the study complained about any discomfort associated with the presence of the sensors
placed on their thorax. The data acquired was compared by the objective B–A method. In the case of
the RR determination for both types of the presented sensors, more than 95% of the values lie within
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the ±1.96 SD range (95.66% for the FOI probe and 95.53% for the FBG probe). In the case of the HR
determination for both types of the presented sensors, again, more than 95% of the values lie within the
±1.96 SD range (96.22% for the FOI probe and 95.23% for the FBG probe). Based on a comparison of
the study results, it can be concluded that the FOI probe offers higher accuracy for the measurements
of human body RR as well as HR. The relative error level during the RR and HR measurements in the
case of both of the fibre-optic sensory systems has not exceeded 5% and is, therefore, acceptable to
clinicians because the systems designed are primarily intended for monitoring rather than diagnosis.
During their verification, the outcomes of this work captivated the attention of clinicians at the
University Hospital (Ostrava, Czech Republic). For this reason, as a next step, the authors of the
publication plan to establish closer cooperation with the doctors, since the clinicians intend to use
these novel sensors in the near future to perform a long-term study on hyperventilation aspects during
MR examinations.
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